Annual report pursuant to Section 13 and 15(d)

Royalty Purchase Agreements (Tables)

v3.20.4
Royalty Purchase Agreements (Tables)
12 Months Ended
Dec. 31, 2020
Royalty Purchase Agreements  
Summary of Acquisition of Royalty Rights

The following table summarizes the long-term royalty receivable activities including acquisitions of royalty rights and cash receipts for achievement of contractual milestones during the years ended December 31, 2020 and 2019 (in thousands):

Balance at January 1, 2019

    

$

15,000

Acquisition of royalty rights:

Bioasis

375

Aronora

9,000

Palobiofarma

10,000

Balance at December 31, 2019

    

$

34,375

Acquisition of royalty rights:

Bioasis

 

1,200

Cash receipts for achievement of contractual milestones:

Agenus

 

(1,000)

Balance at December 31, 2020

$

34,575